The Cytoscan HD Array in the Diagnosis of Neurodevelopmental Disorders
AbstractSubmicroscopic chromosomal copy number variations (CNVs), such as deletions and duplications, account for about 15–20% of patients affected with developmental delay, intellectual disability, multiple congenital anomalies, and autism spectrum disorder. Most of CNVs are de novo or inherited rearrangements with clinical relevance, but there are also rare inherited imbalances with unknown significance that make difficult the clinical management and genetic counselling. Chromosomal microarrays analysis (CMA) are recognized as the first-line test for CNV detection and are now routinely used in the clinical diagnostic laboratory. The recent use of CMA platforms that combine classic copy number analysis with single-nucleotide polymorphism (SNP) genotyping has increased the diagnostic yields. Here we discuss the application of the Cytoscan high-density (HD) SNP-array for the detection of CNVs. We provide an overview of molecular analyses involved in identifying pathogenic CNVs and highlight important guidelines to establish pathogenicity of CNV. View Full-Text
Share & Cite This Article
Scionti, F.; Di Martino, M.T.; Pensabene, L.; Bruni, V.; Concolino, D. The Cytoscan HD Array in the Diagnosis of Neurodevelopmental Disorders. High-Throughput 2018, 7, 28.
Scionti F, Di Martino MT, Pensabene L, Bruni V, Concolino D. The Cytoscan HD Array in the Diagnosis of Neurodevelopmental Disorders. High-Throughput. 2018; 7(3):28.Chicago/Turabian Style
Scionti, Francesca; Di Martino, Maria T.; Pensabene, Licia; Bruni, Valentina; Concolino, Daniela. 2018. "The Cytoscan HD Array in the Diagnosis of Neurodevelopmental Disorders." High-Throughput 7, no. 3: 28.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.